El desfibrilador automático implantable. Evitando la muerte súbita

Revista Española de Cardiología Suplementos - Tập 10 - Trang 32A-39A - 2010
Rafael Peinado Peinado1
1Sección de Electrofisiología y Arritmias, Servicio de Cardiología, Hospital Universitario La Paz, Madrid, España

Tài liệu tham khảo

Peinado, 2008, Registro Español de Desfibrilador Automático Implantable. IV Informe Oficial del Grupo de Trabajo de Desfibrilador Implantable de la Sociedad Española de Cardiología (año 2007), Rev Esp Cardiol., 61, 1191, 10.1157/13127850 Zipes, 2006, ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, J Am Coll Cardiol., 48, e247, 10.1016/j.jacc.2006.07.010 Epstein, 2008, ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities, Heart Rhythm., 5, e1, 10.1016/j.hrthm.2008.04.014 González-Torrecilla, 2008, Indicaciones actuales del desfibrilador automático implantable, Rev Esp Cardiol., 8, 3 Tung, 2008, A critical appraisal of implantable cardioverter defibrillator therapy for the prevention of sudden cardiac death, J Am Coll Cardiol., 52, 1111, 10.1016/j.jacc.2008.05.058 Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med., 346, 877, 10.1056/NEJMoa013474 Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive Herat failure, N Engl J Med., 352, 225, 10.1056/NEJMoa043399 Curtis, 2003, The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure, J Am Coll Cardiol., 42, 736, 10.1016/S0735-1097(03)00789-7 Otterstad, 1997, Accuracy and reproducibility of biplane two-dimensional echocardiograhic measurement of left ventricular dimensions and function, Eur Heart J., 18, 507, 10.1093/oxfordjournals.eurheartj.a015273 Raphael, 2007, Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure, Heart., 93, 476, 10.1136/hrt.2006.089656 Buxton, 2007, Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study, J Am Coll Cardiol., 50, 1150, 10.1016/j.jacc.2007.04.095 Goldenberg, 2008, Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction, J Am Coll Cardiol., 51, 288, 10.1016/j.jacc.2007.08.058 Peinado, 2009, Registro Español de Desfibrilador Automático Implantable (DAI) 2008. V Informe Oficial del Grupo de Trabajo de Desfibrilador Automático Implantable de la SEC, Rev Esp Cardiol., 62, 1435, 10.1016/S0300-8932(09)73128-8 Proclemer, 2009, Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 005-2007, Europace., 11, 465, 10.1093/europace/eun370 National Institute for Health and Clinical Excellence. Implantable cardioverter defibrillator for arrhythmias. Review of technology appraisal 11. Disponible en: www.nice.org.uk/TA095. Parkes, 2005, Inequity of use of implantable cardioverter defibrillators in England: retrospective analysis, BMJ., 330, 454, 10.1136/bmj.38337.635648.82 Ovsyshcher, 2003, Determinants of geographic variations in pacemakers and implantable cardioverter defibrillators implantation rates, PACE., 26, 474, 10.1046/j.1460-9592.2003.00075.x Plummer, 2003, An audit of the implications of implementing NICE guidance on the use of implantable cardioverter-defibrillators, Heart., 89, 787, 10.1136/heart.89.7.787 Martí, 2004, Prevalencia y evolución en España de los pacientes con infarto agudo de miocardio y fracción de eyección severamente deprimida con criterios de implantación de un desfibrilador automático, Rev Esp Cardiol., 57, 705, 10.1157/13064199 González, 2005, Impacto de la angioplastia primaria en la indicación de desfibrilador implantable en pacientes con infarto de miocardio, Rev Esp Cardiol., 58, 1182 Marrugat, 2002, Epidemilogía de la cardiopatía isquémica en España: estimación del número de casos y de las tendencias entre 1997 y 2005, Rev Esp Cardiol., 55, 337, 10.1016/S0300-8932(02)76611-6 Fitch-Warner, 2006, Variabilidad entre comunidades autónomas en el uso de tres tecnologías cardiovasculares, Rev Esp Cardiol., 59, 1232, 10.1157/13096594 Shah, 2009, Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure. Data from the GWTG-HF Registry, J Am Coll Cardiol., 53, 416, 10.1016/j.jacc.2008.09.045 Myerburg, 1998, Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact, Circulation., 97, 1514, 10.1161/01.CIR.97.15.1514 Gehi, 2005, Primary prophylaxis with the implantable cardioverter-defibrillator. The need for improved risk stratification, JAMA., 294, 958, 10.1001/jama.294.8.958 Chan, 2006, Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-elegible population, J Am Coll Cardiol., 48, 112, 10.1016/j.jacc.2006.02.051 Mehra, 2007, Where are we, and where are we heading in the device management of ventricular tachycardia/ventricular fibrillation?, Heart Rhythm., 4, 99, 10.1016/j.hrthm.2006.09.010 Healey, 2007, Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias, Eur Heart J., 28, 1746, 10.1093/eurheartj/ehl438 Mark, 2006, Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), Circulation., 114, 135, 10.1161/CIRCULATIONAHA.105.581884 Zwanziger, 2006, The cost-effectiveness of implantable cardioverter-defibrillator: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT II), J Am Coll Cardiol., 47, 2310, 10.1016/j.jacc.2006.03.032 Wilkoff, 2008, HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations, Europace., 10, 707, 10.1093/europace/eun122 Burri, 2009, Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators, Europace., 11, 701, 10.1093/europace/eup110